Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fertility Lab Sciences LLC is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution of this matter involves 1 distinct examiner, reflecting a very focused interaction with the USPTO. This singular focus suggests that the company's current patenting efforts are concentrated on a specific technological advancement or a single application.
The company's active prosecution is limited to 1 distinct art unit, which centralizes the technical scrutiny of its claims. STEPHEN THOMAS KAPUSHOC is the busiest examiner for the company, currently overseeing 1 pending office action. Since this examiner is the only one with an active case, the company's immediate progress in the patent office is entirely dependent on the outcomes of his reviews.
With 1 pending office action and 1 distinct examiner, the administrative complexity of the portfolio is minimal. However, the reliance on STEPHEN THOMAS KAPUSHOC for the only active matter means that his specific examination style will be the primary factor in the company's short-term success. The concentration in the Biotechnology & Pharmaceuticals sector ensures that the company only needs to address the specific standards and precedents of that single technical group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.5% | +53.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17920336 | METHODS AND KITS FOR IDENTIFYING ADVANCED PATERNAL AGE RELATED EPIGENETIC DYSREGULATION | KAPUSHOC, STEPHEN THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17920336 | METHODS AND KITS FOR IDENTIFYING ADVANCED PATERNAL AGE RELATED EPIGENETIC DYSREGULATION | KAPUSHOC, STEPHEN THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17920336 | METHODS AND KITS FOR IDENTIFYING ADVANCED PATERNAL AGE RELATED EPIGENETIC DYSREGULATION | KAPUSHOC, STEPHEN THOMAS | 1683 | §101§102§103§112 | Final Rejection | — | Pending | Oct 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFertility Lab Sciences LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Stephen Thomas Kapushoc has the most, with 1 of Fertility Lab Sciences LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
